Xcout Intel111, Inc.
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
Subscribe to see 111, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
111, Inc. at a glance
111, Inc. is a healthtech company headquartered in Shanghai, China. It is publicly listed (YI) with a market capitalisation of $31.5M. Xcout tracks 11 named people at 111, Inc., including Anfeng Guo (Chief Innovation Officer).
111, Inc. leadership
- Anfeng GuoChief Innovation Officer
- Junling LiuCo-Founder, Acting Chief Financial Officer, Chairman & Chief Executive Officer
- Gang YuCo-Founder & Executive Chairman
- Alex LiuFinance Director
- Monica MuIR Director
- Gang YuDirector
5 more named people on record for 111, Inc., with roles, board committees and tenure — see the full roster →
Get 111, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on 111, Inc. in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access